The UK’s FTSE 100 experienced a decline on Monday, driven by a decrease in AstraZeneca shares following reports of a possible collaboration with U.S. drugmaker Bristol Myers Squibb. Additionally, lower oil prices negatively impacted energy giants BP and Shell. The blue-chip FTSE 100 index fell 0.10% to 10,857.49 points by 0931, while the mid-cap FTSE Read More